Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment

Antihypertensive medications of the same class could differ by their pharmacodynamic parameters, which substantially affects the longterm treatment results. Nebivolol is one of the modern, highly selective β-adrenoblockers (β-AB). It is characterised not only by high β1-selectivity, but also by addi...

Full description

Bibliographic Details
Main Author: V. B. Mychka
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2012-06-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1829
_version_ 1797882636320899072
author V. B. Mychka
author_facet V. B. Mychka
author_sort V. B. Mychka
collection DOAJ
description Antihypertensive medications of the same class could differ by their pharmacodynamic parameters, which substantially affects the longterm treatment results. Nebivolol is one of the modern, highly selective β-adrenoblockers (β-AB). It is characterised not only by high β1-selectivity, but also by additional vasodilating activity, due to increased nitric oxide synthesis and, hence, beneficial metabolic effects. The results of the original studies and the external evidence demonstrate metabolic neutrality of nebivolol, absence of substantial changes in thyroid hormone levels, and improvement in heart rate variability, electrophysiological myocardial parameters, QT interval duration, and cerebral perfusion. Nebivolol is effective and safe even in higher-risk patients with metabolic syndrome and Type 2 diabetes mellitus.
first_indexed 2024-04-10T03:37:53Z
format Article
id doaj.art-f6e77695fadb4e35ae57a5f33296dbe4
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:37:53Z
publishDate 2012-06-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-f6e77695fadb4e35ae57a5f33296dbe42023-03-13T07:23:21Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252012-06-01113879210.15829/1728-8800-2012-3-87-921544Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatmentV. B. Mychka0Институт клинической кардиологии им. А. Л. Мясникова ФГБУ Российского кардиологического научно-производственного комплекса Минздравсоцразвития России, МоскваAntihypertensive medications of the same class could differ by their pharmacodynamic parameters, which substantially affects the longterm treatment results. Nebivolol is one of the modern, highly selective β-adrenoblockers (β-AB). It is characterised not only by high β1-selectivity, but also by additional vasodilating activity, due to increased nitric oxide synthesis and, hence, beneficial metabolic effects. The results of the original studies and the external evidence demonstrate metabolic neutrality of nebivolol, absence of substantial changes in thyroid hormone levels, and improvement in heart rate variability, electrophysiological myocardial parameters, QT interval duration, and cerebral perfusion. Nebivolol is effective and safe even in higher-risk patients with metabolic syndrome and Type 2 diabetes mellitus.https://cardiovascular.elpub.ru/jour/article/view/1829артериальная гипертензияметаболический синдромсахарный диабетбета-адреноблокаторынебиволол
spellingShingle V. B. Mychka
Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
Кардиоваскулярная терапия и профилактика
артериальная гипертензия
метаболический синдром
сахарный диабет
бета-адреноблокаторы
небиволол
title Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
title_full Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
title_fullStr Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
title_full_unstemmed Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
title_short Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
title_sort benefits of vasodilating beta adrenoblockers for arterial hypertension treatment
topic артериальная гипертензия
метаболический синдром
сахарный диабет
бета-адреноблокаторы
небиволол
url https://cardiovascular.elpub.ru/jour/article/view/1829
work_keys_str_mv AT vbmychka benefitsofvasodilatingbetaadrenoblockersforarterialhypertensiontreatment